News Details
NCCN Offers Free Patient Assistance Resource App
NCCN has launched its Reimbursement Resource App, which offers patients, providers, case managers, and payers access to payment assistance and reimbursement programs for multiple cancer types; the app is available free of charge for Apple and Android™ mobile devices.
FORT WASHINGTON, PA — The National Comprehensive Cancer Network® (NCCN®) announces the availability of the NCCN Reimbursement Resource App, a free resource through which patients with cancer, providers, case managers, and payers can search for available reimbursement resources and patient assistance programs for multiple cancer types and supportive care indications. The app is available free of charge via the Apple Store™ and Google Play™ Store and can be found by searching "NCCN Reimbursement."
"Patients with cancer and their caregivers continue to struggle with the financial burden of a cancer diagnosis," said C. Lyn Fitzgerald, MJ, Vice President, U.S. and Global Development, NCCN. "By making the NCCN Reimbursement Resource App available free of charge, NCCN seeks to assist patients, caregivers, and providers in identifying resources that may ease that burden by providing easy access to payment assistance and reimbursement programs, respectively."
Available for both Apple and Android™ mobile devices, the NCCN Reimbursement Resource App includes interfaces tailored for each of three audiences—patient or caregiver, payer or case manager, and physician or provider-through which users can search for payment programs by three categories: cancer type or supportive care indication, drug name, or reimbursement or assistance program.
Content contained within the NCCN Reimbursement Resource App is updated simultaneously with the NCCN Virtual Reimbursement Resource Room on NCCN.org. The NCCN Virtual Reimbursement Resource Room was launched in 2009 in an effort to provide a payment assistance information resource that covered a variety of cancer types and supportive care indications.
Technical development of this mobile app is supported by ARIAD Pharmaceuticals, Inc.; Genentech, a Member of the Roche Group; and Teva Oncology.
For more information about the NCCN Reimbursement Resource App, visit NCCN.org.
Apple is a trademark of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc.
Google Play is a trademark of Google Inc. Android is a registered trademark of Google.